Skip to main content
Coloplast logo

Coloplast — Investor Relations & Filings

Ticker · COLO ISIN · DK0060448595 LEI · 529900NN7SOJ5QG82X67 CO Manufacturing
Open in API
Filings indexed 2,485 across all filing types
Latest filing 2019-08-19 Director's Dealing
Country DK Denmark
Listing CO COLO

About Coloplast

https://www.coloplast.com

Coloplast is a company that develops, manufactures, and markets medical devices and services for people with intimate healthcare needs. Its principal business areas include Ostomy Care, Continence Care, Interventional Urology, and Wound & Skin Care. By collaborating closely with users, the company creates solutions designed to make life easier for individuals with personal and private medical conditions. Coloplast also provides comprehensive support programs and educational resources for both patients and healthcare professionals.

Recent filings

Filing Released Lang Actions
Trading in Coloplast shares by board members, executives or associated persons
Director's Dealing Classification · 100% confidence The document is a formal notification of transactions in Coloplast shares by a person with managerial responsibilities (Lars Rasmussen, Bestyrelsesformand). It explicitly references the Market Abuse Regulation (Markedsmisbrugsforordningen) Article 19, which mandates the disclosure of insider dealings. The document provides detailed tables of share options exercised and subsequent share sales, including dates, prices, and volumes. This fits the definition of a Director's Dealing report.
2019-08-19 English
Trading in Coloplast shares by board members, executives or associated persons
Director's Dealing Classification · 100% confidence The document title 'Bestyrelsesmedlemmers, direktørers eller nærtstående personers handel med Coloplast-aktier' translates to 'Trading in Coloplast shares by board members, directors or closely related persons'. This is a standard notification for insider trading. Since the document is very short (453 characters) and directs the reader to an attached PDF for the actual details of the transactions, it fits the definition of a Director's Dealing notification.
2019-08-19 English
Director's Dealing 2019
Director's Dealing Classification · 100% confidence The document is titled "Report on transactions of executives and related parties in Coloplast shares and related securities" and explicitly references compliance with "Market Abuse Regulation article 19". It details the 'Exercise of share options (purchase)' and 'Sale of shares' by a Chairman of the Board of Directors (Lars Rasmussen). This content directly corresponds to the reporting requirements for insider transactions by management, which is classified as Director's Dealing (DIRS). It is not a general earnings release (ER), a full annual report (10-K), or a proxy statement (DEF 14A/PSI).
2019-08-19 English
Director's Dealing 2019
Director's Dealing Classification · 98% confidence The document text is extremely short (426 characters) and explicitly states 'Trading in Coloplast shares by board members, executives or associated persons' and directs the reader to an enclosed PDF attachment. This content directly relates to personal share transactions by directors and executives. According to the definitions, 'Director's Dealing' (Code: DIRS) covers the 'Report of personal share transactions by company directors and executives (insider trades)'. Since this document is merely an announcement pointing to the actual report (PDF), it could potentially be RPA or RNS based on the 'MENU VS MEAL' rule. However, the subject matter is so specific to DIRS that it is more accurately classified as DIRS, assuming the attached PDF contains the required disclosure details, and this announcement serves as the primary filing mechanism for that specific event type. Given the highly specific nature of the content matching the DIRS definition, I will classify it as DIRS, acknowledging the short length suggests it's an announcement of the filing.
2019-08-19 English
Share buy-back week 33/2019
Transaction in Own Shares Classification · 100% confidence The document is an announcement from Coloplast regarding transactions made under their share buy-back programme. It details specific share purchase dates, quantities, and prices, and explicitly mentions the company's treasury share holdings. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS), which covers share repurchases.
2019-08-19 English
Aktietilbagekøb uge 33/2019
Transaction in Own Shares Classification · 100% confidence The document is a corporate announcement from Coloplast regarding the execution of a share buyback program ('aktietilbagekøbsprogram'). It details specific transactions (number of shares, price, and total amount) conducted between August 12 and August 16, 2019, under a 'Safe Harbour' regulatory framework. This falls directly under the definition of 'Transaction in Own Shares' (POS).
2019-08-19 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.